Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Free Cash Flow Generation Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Free Cash Flow Generation Index of -0.27x as of September 2025. Free cash flow of CN¥-2.50 Million represents 0% of operating cash flow (CN¥9.12 Million). Read 300942 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shenzhen Bioeasy Biotechnology Co. Ltd. Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Explore 300942 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year Free Cash Flow Generation Index for Shenzhen Bioeasy Biotechnology Co. Ltd.. For the full company profile including market capitalisation, see 300942 market cap.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CN¥20.97 Million | CN¥66.87 Million | CN¥45.90 Million | ▲ +107.7% |
| 2024 | -4.08x | CN¥-139.85 Million | CN¥34.26 Million | CN¥174.10 Million | ▼ -2463.4% |
| 2022 | -0.16x | CN¥-24.29 Million | CN¥152.55 Million | CN¥176.85 Million | ▼ -123.1% |
| 2021 | 0.69x | CN¥175.92 Million | CN¥255.42 Million | CN¥79.51 Million | ▲ +330.7% |
| 2020 | -0.30x | CN¥-19.04 Million | CN¥63.79 Million | CN¥82.84 Million | ▼ -149.0% |
| 2019 | 0.61x | CN¥40.95 Million | CN¥67.24 Million | CN¥26.29 Million | ▼ -25.6% |
| 2018 | 0.82x | CN¥47.40 Million | CN¥57.93 Million | CN¥10.53 Million | ▲ +51.1% |
| 2017 | 0.54x | CN¥12.79 Million | CN¥23.60 Million | CN¥10.82 Million | ▼ -27.9% |
| 2016 | 0.75x | CN¥27.29 Million | CN¥36.31 Million | CN¥9.03 Million | — |